GRAL
GRAIL, Inc.
GRAIL, Inc. (GRAL) has 15 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 16, 2026.
Insiders have net sold $11.6M over the trailing 6 months.
- Industry:Medical - Diagnostics & Research
- CEO:Robert Ragusa
- Employees:1,000
- HQ:Menlo Park, CA, US
- IPO:2024-06-12
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$11.6M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$2.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Partridge Andrew JohnFirst filing | Chief Growth Officer | Sale | 1,491 | $91K | Jun 6 | SEC ↗ |
Freidin AaronFirst filing | Chief Financial Officer | Sale | 45,806 | $2.3M | Apr 9 | SEC ↗ |
RAGUSA ROBERT PFirst filing | Chief Executive Officer | Sale | 123,502 | $6.2M | Apr 9 | SEC ↗ |
Ofman Joshua J.First filing | President | Sale | 61,665 | $3.1M | Apr 9 | SEC ↗ |
Related companies
GRAIL, Inc. is in the Healthcare sector.